A growing surge of antibiotic-resistant infections is placing renewed pressure on public health systems across England, with the latest UKHSA surveillance showing nearly 400 resistant cases reported each week. The findings highlight rising mortality rates, widening social inequalities and an urgent need for stronger stewardship across both NHS and private healthcare settings.
In 2024, the UK Health Security Agency reported a sharp rise in antibiotic-resistant infections across England, driven by higher private-sector prescribing, increased bloodstream infections and widening deprivation gaps. The trend raises concerns for clinicians and communities as evidence shows resistance continues to outpace national prevention efforts.
Scale of Antibiotic-Resistant Infections in 2024
Antibiotic-resistant bacteraemia cases increased by 9.3% in 2024, rising from 18,740 in 2023 to 20,484. These infections represent some of the most severe forms of bacterial illness, often leading to extended hospital stays, organ complications and higher mortality.
UKHSA data shows 2,379 deaths in 2024 involved resistant infections—338 more than the previous year. Moreover, E. coli continues to dominate bloodstream infections, accounting for 65% of cases over the last six years.
While resistance occurs naturally, the growing scale indicates that current prescribing patterns and infection-prevention efforts need to accelerate.
Private Prescribing and Changing Antibiotic Use
Between 2019 and 2024, NHS primary care antibiotic use decreased. However, private dispensing more than doubled, driving a 10.7% overall rise in primary care antibiotic use. In 2024, 22% of all primary care antibiotics were issued through private prescriptions, a shift many experts regard as a warning sign.
NHS antibiotic use is now 2% lower than pre-pandemic levels, but general practice and dentistry prescribing remain below 2019 rates. Meanwhile, new Pharmacy First data shows the service accounted for 4% of primary care antibiotics in 2024.
Why Older Adults Face Higher Risks
Older adults account for 90% of all resistant infections, with nearly half occurring in those over 74. Age-related immune decline, higher rates of chronic illness and greater exposure to medical procedures all compound the risk.
Repeated antibiotic use over a lifetime further increases the likelihood of resistant strains developing in the body, making infections more complex and harder to treat.
Hospital Exposure and Community Transmission
Longer hospital stays remain strongly associated with resistant infections due to the circulation of organisms such as MRSA, ESBL-producing E. coli and carbapenem-resistant Klebsiella.
However, not all cases originate in hospitals. Many resistant urinary tract infections begin in community settings before progressing to bloodstream infections, affecting both older adults and vulnerable groups.
Widening Inequalities in Resistant Infections
The 2024 data shows a widening gap between the most and least deprived communities. Those living in the most deprived areas experience a 47.2% higher rate of resistant bacteraemia compared with those in the least deprived areas—a significant increase from a 29% gap in 2019.
Contributing factors include overcrowded housing, delayed access to healthcare, and the higher burden of untreated chronic illness that increases exposure to medical interventions.
Prescribing in Younger Groups
Prescribing in children and young people remains above 2019 levels, driven partly by higher infection rates following post-pandemic reopenings. While their absolute risk of resistant infection remains lower than that of older adults, increased antibiotic exposure early in life can contribute to long-term resistance trends.
National Strategy, Solutions and Current Debates
The UK’s national antimicrobial resistance strategy emphasises prevention, stewardship and innovation across healthcare, agriculture and environmental monitoring.
Surveillance improvements now integrate real-world data from hospitals, pharmacies, GPs and environmental sources, helping to track emerging threats sooner.
Actions and Friction Points
Healthcare leaders highlight several focus areas—and associated debates—shaping the UK’s resistance response.
Measures in Focus
-
Stricter stewardship and rapid diagnostic testing.
-
Improved infection-prevention measures and wider vaccination uptake.
-
New funding models for antibiotic development.
Antibiotic-Resistant Infection Trends (2019–2024)
| Indicator | 2019 | 2024 | Change |
|---|---|---|---|
| NHS antibiotic use (DID) | 14.21 | 13.96 | ↓ |
| Private antibiotic dispensing (DID) | 1.95 | 3.93 | ↑↑ |
| Total primary care antibiotic use | — | — | 10.7% rise |
Expert Warnings and Public Health Advice
UKHSA, NHS England and MHRA leaders stress that antibiotic resistance is one of the greatest modern health threats. They urge the public to take antibiotics only when prescribed, avoid sharing or saving medications, dispose of leftovers safely, and stay up to date with vaccinations.
The Final Word
Antibiotic resistance continues to rise across England, fuelled by changing prescribing patterns, demographic risks and widening social inequalities. Although national strategies offer promising pathways, sustained vigilance, responsible antibiotic use and coordinated industry–government action are essential to protect the effectiveness of life-saving treatments for the future.
Sources: UK Health Security Agency, Department of Health and Social Care.
Prepared by Ivan Alexander Golden, Founder of THX News™, an independent news organization delivering timely insights from global official sources. Combines AI-analyzed research with human-edited accuracy and context.
